Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › London › NPI 1982710703
Hospital

Madison County Community Hospital

Madison County Community Hospital was paid $8.55M by Medicaid between Jan 2018 and Dec 2024, across 167 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.

33Billing provider infoMADISON COUNTY COMMUNITY HOSPITAL
LONDON, OH 43140
33aNPI1982710703assigned 08/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.55M
24GClaims222,267
24DCodes billed167
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#81 of 101
Median peer was paid$22.32M
This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201817,781$589K
201916,791$629K
202010,806$574K
202115,684$772K
202219,776$997K
202374,056$2.80M
2024incomplete67,373$2.19M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 21% 15,593 14,704 $1.77M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 11,068 9,921 $1.25M
96361 Intravenous infusion, hydration; each additional hour 13% 3,538 2,719 $1.10M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.8% 4,516 4,005 $580K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 5.5% 6,453 1,749 $474K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 5.1% 5,788 1,834 $436K
97530 Therapeutic activities, direct patient contact, each 15 minutes 4.1% 4,025 1,336 $348K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.0% 2,452 2,320 $258K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.9% 916 762 $246K
80053 Comprehensive metabolic panel 2.1% 15,631 13,930 $181K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.1% 976 589 $179K
70450 Computed tomography, head or brain; without contrast material 1.8% 612 528 $151K
155 more codes
99213 Doctor's office visit, returning patient (routine) 1.5% 1,279 $129K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.3% 548 $110K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 281 $77K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 21,181 $74K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 857 $74K
84443 Thyroid stimulating hormone (TSH) <1% 4,589 $73K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 815 $69K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 419 $62K
99214 Doctor's office visit, returning patient (more involved) <1% 599 $59K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,412 $43K
36415 Collection of venous blood by venipuncture <1% 15,511 $42K
80061 Lipid panel <1% 3,090 $41K
G0378 Hospital observation service, per hour <1% 635 $39K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 484 $38K
97016 <1% 901 $33K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,264 $31K
71046 Radiologic examination, chest; 2 views <1% 1,510 $29K
83036 Hemoglobin; glycosylated (A1C) <1% 2,217 $29K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 4,091 $27K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,153 $24K
73564 <1% 532 $23K
80048 Basic metabolic panel (calcium, ionized) <1% 2,431 $22K
87088 <1% 1,887 $21K
77063 Screening digital breast tomosynthesis, bilateral <1% 435 $21K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 50 $18K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,095 $18K
71275 Computed tomographic angiography, chest, with contrast material <1% 52 $17K
73630 <1% 559 $16K
82607 <1% 849 $15K
73130 <1% 489 $14K
73030 <1% 392 $13K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 389 $13K
97161 <1% 267 $12K
86803 <1% 469 $12K
73610 <1% 427 $11K
59025 Fetal non-stress test <1% 127 $10K
97162 <1% 253 $10K
84439 <1% 502 $10K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,603 $9K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,243 $9K
84484 <1% 3,479 $9K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 360 $7K
84466 <1% 609 $6K
83735 <1% 3,105 $6K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 452 $6K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 389 $6K
77067 Screening mammography, bilateral, including computer-aided detection <1% 436 $6K
62323 <1% 12 $5K
73110 <1% 175 $5K
83540 <1% 619 $5K
82728 <1% 304 $5K
81001 <1% 6,819 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 527 $5K
86780 <1% 177 $4K
86140 <1% 1,035 $4K
81514 <1% 55 $4K
82746 <1% 415 $4K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 242 $4K
87086 Culture, bacterial; quantitative colony count, urine <1% 246 $4K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 54 $4K
87186 <1% 559 $4K
71045 Radiologic examination, chest; single view <1% 1,506 $3K
84153 <1% 231 $3K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 17 $3K
81003 <1% 1,638 $3K
82570 <1% 321 $3K
85610 <1% 1,745 $3K
70551 Magnetic resonance imaging, brain; without contrast material <1% 12 $3K
85652 <1% 606 $2K
J3490 Unclassified drugs <1% 1,556 $2K
72100 <1% 60 $2K
86850 <1% 125 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,797 $2K
84703 <1% 2,309 $2K
85027 <1% 251 $2K
73502 <1% 63 $2K
82565 <1% 489 $2K
83690 <1% 2,606 $2K
83880 <1% 824 $2K
83605 <1% 1,399 $2K
71250 <1% 17 $2K
87340 <1% 66 $1K
82043 <1% 216 $1K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 64 $1K
85730 <1% 1,717 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,048 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 2,805 $1K
82248 <1% 676 $1K
84702 <1% 65 $1K
80051 <1% 273 $1K
82150 <1% 621 $1K
82947 <1% 317 $1K
86900 <1% 128 $1K
73562 <1% 46 $1K
92523 <1% 12 $996.54
J7030 Infusion, normal saline solution , 1000 cc <1% 1,696 $960.35
84520 <1% 470 $835.83
86038 <1% 28 $821.21
96376 <1% 521 $762.52
73080 <1% 31 $680.10
86901 <1% 128 $674.05
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,355 $614.06
84550 <1% 106 $610.53
99204 Doctor's office visit, new patient (more involved) <1% 15 $559.67
74018 <1% 13 $559.18
87077 <1% 497 $498.39
85018 <1% 24 $420.16
77003 <1% 570 $401.34
72125 Computed tomography, cervical spine; without contrast material <1% 19 $378.48
85379 <1% 513 $336.98
90715 <1% 13 $283.10
82550 <1% 61 $227.08
87070 <1% 57 $216.70
J1170 Injection, hydromorphone, up to 4 mg <1% 704 $160.26
84481 <1% 17 $146.09
80076 <1% 13 $120.59
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,448 $118.30
87634 <1% 329 $116.10
J2270 Injection, morphine sulfate, up to 10 mg <1% 594 $108.78
J2550 Injection, promethazine hcl, up to 50 mg <1% 347 $100.17
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,253 $57.16
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 628 $52.78
87205 <1% 37 $45.38
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 419 $28.92
J1815 Injection, insulin, per 5 units <1% 19 $25.16
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,870 $24.12
84156 <1% 12 $20.14
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 541 $16.00
J2704 Injection, propofol, 10 mg <1% 984 $15.87
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 361 $6.58
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 172 $5.87
J3360 Injection, diazepam, up to 5 mg <1% 14 $5.45
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 215 $5.12
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 291 $5.05
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 63 $5.00
J3010 Injection, fentanyl citrate, 0.1 mg <1% 345 $3.64
J1596 Injection, glycopyrrolate, 0.1 mg <1% 120 $3.53
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 209 $3.30
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 168 $2.18
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 99 $2.07
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 191 $0.92
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 33 $0.58
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 223 $0.53
J1940 Injection, furosemide, up to 20 mg <1% 27 $0.05
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 2,003 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 180 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 38 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 18 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 45 $0.00
A9270 Non-covered item or service 0% 762 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 95 $0.00
00813 0% 12 $0.00
82803 0% 70 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 13 $0.00
J2060 Injection, lorazepam, 2 mg 0% 18 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKOLB, FRED (CEO)